Academic staff at First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University, Faculty of Pharmacy in Hradec Králové
Publications
- Outcome of patients with diffuse large B-cell lymphoma and testicular involvement - real world data2025 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Blood Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial2025 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- The Lancet: Oncology Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study2025 | Faculty of Medicine in Hradec Králové
- Onkologická revue Epkoritamab v léčbě v léčbě difuzního velkobuněčného B lymfomu2025 | Faculty of Medicine in Hradec Králové
- Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study2024 | Third Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Several factors that predict the outcome of large B-cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T-cell therapy can be identified before cell administration2024 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia2024 | Faculty of Medicine in Hradec Králové
- Epcoritamab in the treatment of diffuse large B-cell lymphoma2024 | Faculty of Medicine in Hradec Králové
- Complex evaluation of serum immunoglobulin levels in patients with chronic lymphocytic leukemia: Significant increase in IgA after first-line chemoimmunotherapy2024 | Faculty of Medicine in Hradec Králové
- Pirtobrutinib v léčbě nemocných s lymfomem z buněk pláště2024 | Faculty of Medicine in Hradec Králové
Loading network view...
